RxFiles ADHD

ADHD Newsletter

The ADHD newsletter, “Medication Pearls,” highlights practical clinical pearls to support individualized stimulant selection based on medication characteristics and patient-specific factors. It aims to build clinician confidence in initiating stimulant therapy, optimizing titration and monitoring, and ensuring an adequate therapeutic trial has been completed. The newsletter also provides practical strategies for managing common challenges encountered when adjusting stimulant therapy. In addition, it discusses when to consider second-line non-stimulant options following multiple stimulant failures, along with practical prescribing tips for initiation and ongoing management.

ADHD Drug Comparison Chart

The drug comparison chart provides an overview of ADHD and practical prescribing information for stimulant and non-stimulant medication classes. It highlights key clinical and therapeutic pearls to support individualized drug therapy selection, prescribing, and ongoing management.

CADDRA ADHD Assessment Toolkit (CAAT) [External Link]

This CADDRA website contains assessment and follow-up forms for children/adolescents and adults, as well as instructions for using the various tools.

CADDRA Guide to ADHD Pharmacological Treatments in Canada [External Link]

The CADDRA Guide compares amphetamine-based psychostimulants, methylphenidate-based psychostimulants, and non-psychostimulants.

Centre for ADHD Awareness Canada (CADDAC) [External Link]

CADDAC provides leadership in awareness, education, and advocacy for ADHD across Canada. CADDAC is committed to increasing the understanding of ADHD. CADDAC's programs support parents and individuals affected by ADHD.

Evidence-Based Interventions for ADHD
[External Link]

Shared decision-making tool based on the best available evidence to help clinicians, people with ADHD, and their carers make informed choices. Interventions include medication and non-medication alternatives.

RxFiles: ADHD